“This expanded strategic partnership benefits both organizations and, ultimately, our customers,” stated Dr. Ian Moore, Vice President, WACKER SILICONES NCA region. “Many of our customers’ processes include silicone rubber for multi-industry applications. With the SILPURAN® product line consisting of a large portfolio of HCRs and LSRs, the extended partnership with H.M. Royal creates a one-stop shop for customers’ LSR and HCR silicone needs.”
H.M. Royal and WACKER’s partnership began in 2016, when H.M. Royal started serving as distributor of WACKER’s ELASTOSIL® line which consists of LSRs and HCRs used in many standard and generally less sensitive medical applications such as medical wearables, tubing, patches, and similar products. In 2019, H.M. Royal began also offering WACKER’s room temperature curing (RTV) product lines.
The products in the SILPURAN® portfolio are designed specifically for applications such as wound dressings, medical adhesives, gels, intravenous (IV) administration sets, needle-free valves and seals, drainage and feeding tubes, urinary catheters, syringe seals, respiratory masks and similar medical pplications.
SILPURAN® products have met ISO 10993 standards and passed United States Pharmacopoeia (USP) Class VI tests, and they are filled and packaged in Class 8 clean rooms. The outstanding levels of purity needed for fulfilling current and future medical requirements are ensured by the WACKER CLEAN OPERATIONS program.
With the increased U.S. demand for common medical products, production of WACKER’s medical-grade silicones have been prioritized and the company continues to meet customer needs for short lead times.
“Combining resources with H.M. Royal supports the health care industry’s needs for speed and quality in the delivery of solutions,” stated Jake Carlson, Business Development Manager at WACKER Distribution Management.
